Related Experiment Video
Updated: May 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Pharmacoeconomic evaluation for the treatment of rheumatoid arthritis]
1School of Public Health, Fudan University, Shanghai 200032, China. liub@fudan.edu.cn
Objective:
To conduct pharmacoeconomic evaluations for the two therapies of rheumatoid arthritis (RA).
Methods:
An expert survey was conducted on the cost and effectiveness of two RA therapies of methotrexate (MTX) alone and recombinant human tumor necrosis factor-α receptor II:IgG Fc fusion protein (rhTNFR:Fc) plus MTX, followed by simulation estimates, and cost-effectiveness analysis on the basis of pharmacoeconomic Markov model.
Results:
MTX alone and rhTNFR:Fc plus MTX cost RMB 1422 Yuan and RMB13 000 Yuan respectively per treatment cycle (3 months). Five-year Markov model showed that the incremental cost-effectiveness ratio of rhTNFR:Fc plus MTX was RMB 99 662 Yuan per QALY when compared with MTX alone. And it was lower than the threshold of willingness to pay.
Conclusion:
The patients with RA on the combined treatment of rhTNFR:Fc and MTX may have potential long-run economic advantage over those on the treatment of MTX alone.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease IV: Nursing Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
